Cord blood transplantation: Can we make it better?

Frontiers in Oncology

Volumn 3 SEP, Issue , 2013, Pages

  Metheny, Leland ^a   Caimi, Paolo ^a   De Lima, Marcos ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Delayed engraftment; Double umbilical cord transplant; Ex vivo expansion; Mesenchymal stem cells; Reduced intensity conditioning; Umbilical cord blood transplantation

Indexed keywords

BUSULFAN; CD45 ANTIGEN; COPPER; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHELATION; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT FAILURE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; LEUKEMIA; MORTALITY; NEUTROPHIL; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; STEM CELL EXPANSION; SURVIVAL RATE; THROMBOCYTE; UMBILICAL CORD;

EID: 84891140189     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00238     Document Type: Review

References (91)

1. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-matched sibling. N Engl J Med (1989) 321:1174-8. doi:10.1056/NEJM198910263211707
2. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood (1993) 81:1679-90.
3. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 92:10119-22. doi:10.1073/pnas.92.22.10119
4. Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A (1992) 89:4109-13. doi:10.1073/pnas.89.9.4109
5. Barker JN, Byam CE, Kernan NA, Lee SS, Hawke RM, Doshi KA, et al. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biol Blood Marrow Transplant (2010) 16(11):1541-8. doi:10.1016/j.bbmt.2010.08.011
6. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (1995) 346:214-9. doi:10.1016/S0140-6736(95)91268-1
7. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood (1996) 88(3):795-802.
8. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood (2001) 97(10):2957-61. doi:10.1182/blood.V97.10.2957
9. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1997) 339:1565-77. doi:10.1056/NEJM199811263392201
10. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord transplant group and the European blood and marrow transplantation group. N Engl J Med (1997) 337:373-81. doi:10.1056/NEJM199708073370602
11. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 97(10):2962-71. doi:10.1182/blood.V97.10.2962
12. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet (2007) 369(9577):1947-54. doi:10.1016/S0140-6736(07)60915-5
13. Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D, et al. Results of the cord blood transplantation study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood (2008) 112:4318-27. doi:10.1182/blood-2007-06-098020
14. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood (2002) 100(5):1611-8.
15. Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-cord blood transplant group. Blood (1999) 93:3662-71.
16. Gluckman E, Rocha V. Cord blood transplantation for children with acute leukaemia: a Eurocord registry analysis. Blood Cells Mol Dis (2004) 33:271-3.
17. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 344(24):1815-22. doi:10.1056/NEJM200106143442402
18. Sanz GF, Saavedra S, Planelles D, Senent L, Cervera J, Barragán E, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood (2001) 98:2332-8. doi:10.1182/blood.V98.8.2332
19. Cornetta K, Laughlin M, Carter S, Wall D, Weinthal J, Delaney C, et al. Umbilical cord blood transplantation in adults: results of the prospective cord blood transplantation (COBLT). Biol Blood Marrow Transplant (2005) 11:149-60. doi:10.1016/j.bbmt.2004.11.020
20. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood (2004) 104:3813-20. doi:10.1182/blood-2004-03-1001
21. Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant (2007) 13(1):82-9. doi:10.1016/j.bbmt.2006.08.041
22. Hamza NS, Lisgaris M, Yadavalli G, Nadeau L, Fox R, Fu P, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol (2004) 124:488-98. doi:10.1046/j.1365-2141.2003.04792.x
23. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med (2004) 351:2276-85. doi:10.1056/NEJMoa041469
24. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol (2010) 11:653-60. doi:10.1016/S1470-2045(10)70127-3
25. Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, et al. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol (2011) 12:1214-21. doi:10.1016/S1470-2045(11)70260-1
26. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood (1998) 91:756-63.
27. Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, Leitman S, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood (1999) 94:3234-41.
28. Sykes M, Preffer F, McAfee S, Saidman SL, Weymouth D, Andrews DM, et al. Mixed lymphohaemopoietic chimerism and graft-versus lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet (1999) 353:1755-9. doi:10.1016/S0140-6736(98)11135-2
29. Khouri IF, Keating M, Körbling M, Przepiorka D, Anderlini P, O'Brien S, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol (1998) 16:2817-24.
30. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med (2000) 343:750-8. doi:10.1056/NEJM200009143431101
31. Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C, et al. Melphalan and purine analog-containing preparative regimens: reduced intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood (2001) 97:631-7. doi:10.1182/blood.V97.3.631
32. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus tumor effects. Blood (2001) 97:3390-400. doi:10.1182/blood.V97.11.3390
33. Nagler A, Aker M, Or R, Naparstek E, Varadi G, Brautbar C, et al. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. Exp Hematol (2001) 29:362-70. doi:10.1016/S0301-472X(00)00655-X
34. Chakraverty R, Peggs K, Chopra R, Milligan DW, Kottaridis PD, Verfuerth S, et al. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood (2002) 99:1071-8. doi:10.1182/blood.V99.3.1071
35. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood (2003) 102:1915-9. doi:10.1182/blood-2002-11-3337
36. Brunstein CG, Eapen M, Ahn KW, Appelbaum FR, Ballen KK, Champlin RE, et al. Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. Blood (2012) 119(23):5591-8. doi:10.1182/blood-2011-12-400630
37. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med (2001) 344(24):1870-1. doi:10.1056/NEJM200106143442417
38. De Lima M, St John LS, Wieder ED, Lee MS, McMannis J, Karandish S, et al. Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol (2002) 119(3):773-6. doi:10.1046/j.1365-2141.2002.03893.x
39. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood (2005) 105:1343-7.
40. MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR, et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood (2009) 113:2410-5. doi:10.1182/blood-2008-07-163238
41. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood (2007) 110(8):3064-70. doi:10.1182/blood-2007-04-067215
42. Kindwall-Keller TL, Hegerfeldt Y, Meyerson HJ, Margevicius S, Fu P, van Heeckeren W, et al. Prospective study of single vs. two unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematologic malignancies. Bone Marrow Transplant (2012) 47(7):924-33. doi:10.1038/bmt.2011.195
43. Wagner JE, Eapen M, Carter SL, Haut PR, Peres E, Schultz KR, et al. No Survival Advantage after Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial [Presentation]. ASH (2012).
44. Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood (2010) 116:4693-9. doi:10.1182/blood-2010-05-285304
45. Avery S, Shi W, Lubin M, Gonzales AM, Heller G, Castro-Malaspina H, et al. Influence of infused cell dose and HLA-match on engraftment after double-unit cord blood allografts. Blood (2011) 117(12):3277-85. doi:10.1182/blood-2010-08-300491
46. Arcese W, Rocha V, Labopin M, Sanz G, Iori AP, de Lima M, et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica (2006) 91:223-30.
47. Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplant outcome in 1061 cord blood recipients with hematological malignancies. Blood (2010) 115(9):1843-9. doi:10.1182/blood-2009-07-231068
48. Barker JN, Byam C, Scaradavou A. How I treat: the selection and acquisition of unrelated cord blood grafts. Blood (2011) 117(8):2332-9. doi:10.1182/blood-2010-04-280966
49. Fernández MN, Regidor C, Cabrera R, García-Marco JA, Forés R, Sanjuán I, et al. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol (2003) 31(6):535-44. doi:10.1016/S0301-472X(03)00067-5
50. Liu H, Rich ES, Godley L, Odenike O, Joseph L, Marino S, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood (2011) 118:6438-45. doi:10.1182/blood-2011-08-372508
51. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex-vivo expanded cord blood. Biol Blood Marrow Transplant (2002) 8:368-76. doi:10.1053/bbmt.2002.v8.pm12171483
52. de Lima M, McMannis J, Komaduri K, Worth L, Karandish S, Jones R, et al. Randomized study of double cord blood transplantation (CBT)with versus without ex vivo expansion (EXP). Presented at the 49th Annual Meeting of the American Society of Hematology. Atlanta (2007). [Abstract].
53. Robinson SN, Ng J, Niu T, Yang H, McMannis JD, Karandish S, et al. Superior ex vivo cord blood expansion following co-culture with bone marrow derived mesenchymal stem cells. Bone Marrow Transplant (2006) 37:359-66. doi:10.1038/sj.bmt.1705258
54. de Lima M, McNiece I, Robinson SN, Munsell M, Eapen M, Horowitz M, et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Eng J Med (2012) 367(24):2305-15. doi:10.1056/NEJMoa1207285
55. Verfaillie CM. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood (1992) 79:2821-6.
56. Choudhury C. Role of the microenvironment on hematopoiesis. I. Stem cell differentiation into granulocytic and megakaryocytic cell lineage. J Lab Clin Med (1989) 114:378-81.
57. Harigaya K, Handa H. Generation of functional clonal cell lines from human bone marrow stroma. Proc Natl Acad Sci U S A (1985) 82:3477-80. doi:10.1073/pnas.82.10.3477
58. Gordon MY, Clarke D, Atkinson J, Greaves MF. Hemopoietic progenitor cell binding to the stromal microenvironment in vitro. Exp Hematol (1990) 18:837-42.
59. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop Relat Res (1980) 151:294-307.
60. Beresford JN. Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Relat Res (1989) 240:270-80.
61. Bab I, Passi-Even L, Gazit D, Sekeles E, Ashton BA, Peylan-Ramu N, et al. Osteogenesis in in vivo diffusion chamber cultures of human marrow cells. Bone Miner (1988) 4:373-86.
62. Cheng L, Mbalaviele G, Liu X. Human mesenchymal stem cell support proliferation and multilineage differentiation of human hematopoietic stem cells. Blood (1998) 92:57a.
63. MacMillan ML, Blazar BR, DeFor TE, Wagner JE. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant (2009) 43:447-54. doi:10.1038/bmt.2008.348
64. Peled T, Landau E, Prus E, Treves AJ, Nagler A, Fibach E. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. Br J Haematol (2002) 116:655-61. doi:10.1046/j.0007-1048.2001.03316.x
65. Peled T, Glukhman E, Hasson N, Adi S, Assor H, Yudin D, et al. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. Exp Hematol (2005) 33:1092-100. doi:10.1016/j.exphem.2005.06.015
66. Peled T, Mandel J, Goudsmid RN, Landor C, Hasson N, Harati D, et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy (2004) 6:344-55. doi:10.1080/14653240410004916
67. Peled T, Landau E, Mandel J, Glukhman E, Goudsmid NR, Nagler A, et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol (2004) 32:547-55. doi:10.1016/j.exphem.2004.03.002
68. de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson BS, et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant (2008) 41:771-8. doi:10.1038/sj.bmt.1705979
69. Kojika S, Griffin JD. Notch receptors and hematopoiesis. Exp Hematol (2001) 29(9):1041-52. doi:10.1016/S0301-472X(01)00676-2
70. Milner LA, Kopan R, Martin DI, Bernstein ID. A. Blood (1994) 83(8):2057-62.
71. Karanu FN, Murdoch B, Gallacher L, Wu DM, Koremoto M, Sakano S, et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med (2000) 192(9):1365-72. doi:10.1084/jem.192.9.1365
72. Karanu FN, Murdoch B, Miyabayashi T, Ohno M, Koremoto M, Gallacher L, et al. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood (2001) 97(7):1960-7. doi:10.1182/blood.V97.7.1960
73. Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S, et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med (2000) 6(11):1278-81. doi:10.1038/81390
74. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med (2010) 16:232-6. doi:10.1038/nm.2080
75. vanHennik PB, de Koning AE, Ploemacher RE. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood (1999) 94:3055-61.
76. Cui J, Wahl RL, Shen T, Fisher SJ, Recker E, Ginsburg D, et al. Bone marrow cell trafficking following intravenous administration. Br J Haematol (1999) 107:895-902. doi:10.1046/j.1365-2141.1999.01779.x
77. Kushida T, Inaba M, Hisha H, Ichioka N, Esumi T, Ogawa R, et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood (2001) 97:3292-9. doi:10.1182/blood.V97.10.3292
78. Zhong JF, Zhan Y, Anderson WF, Zhao Y. Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation. Blood (2002) 100:3521-6. doi:10.1182/blood-2002-04-1256
79. Mazurier F, Doedens M, Gan OI, Dick JE. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med (2003) 9:959-63. doi:10.1038/nm886
80. Yahata T, Ando K, Sato T, Miyatake H, Nakamura Y, Muguruma Y, et al. A highly sensitive strategy for SCID repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood (2003) 101:2905-13. doi:10.1182/blood-2002-07-1995
81. Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y, et al. SCID-repopulating cell activity of human cord blood derived CD34-cells assured by intra-bone marrow injection. Blood (2003) 101:2924-31. doi:10.1182/blood-2002-09-2782
82. Castello S, Podestà M, Menditto VG, Ibatici A, Pitto A, Figari O, et al. Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol (2004) 32:782-7. doi:10.1016/j.exphem.2004.05.026
83. Nakamura K, Inaba M, Sugiura K, Yoshimura T, Kwon AH, Kamiyama Y, et al. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion. Stem Cells (2004) 22:125-34. doi:10.1634/stemcells.22-2-125
84. Nishida T, Hosaka N, Takaki T, Miyake T, Cui W, Inaba M, et al. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection. Bone Marrow Transplant (2009) 43:829-37. doi:10.1038/bmt.2008.396
85. Miyake T, Hosaka N, Cui W, Nishida T, Takaki T, Inaba M, et al. Adult thymus transplantation with allogeneic intra-bone marrow-bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effects. Immunology (2009) 126:552-64. doi:10.1111/j.1365-2567.2008.02920.x
86. Hägglund H, Ringdén O, Agren B, Wennberg L, Remberger M, Rundquist L, et al. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transplant (1998) 21:331-5. doi:10.1038/sj.bmt.1701116
87. Frassoni F, Gualandi F, Podesta M, Raiola AM, Ibatici A, Piaggio G, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol (2008) 9:831-9. doi:10.1016/S1470-2045(08)70180-3
88. Marini C, Podestà M, Massollo M, Capitanio S, Fiz F, Morbelli S, et al. Intrabone transplant of cord blood stem cells establishes a local engraftment store: a functional PET/FDG study. J Biomed Biotechnol (2012) 2012:767369. doi:10.1155/2012/767369
89. Brunstein CG, Barker JN, Weisdorf DJ, Defor TE, McKenna D, Chong SY, et al. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant (2009) 43:935-40. doi:10.1038/bmt.2008.417
90. Carrancio S, Romo C, Ramos T, Lopez-Holgado N, Muntion S, Prins HJ, et al. Effects of MSC-co-administration and route of delivery on cord blood hematopoietic stem cell engraftment. Cell Transplant (2013) 22(7):1171-83. doi:10.3727/096368912X657431
91. Robinson SN, Simmons PJ, Thomas MW, Brouard N, Javni JA, Trilok S, et al. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2R?(null) mice. Exp Hematol (2012) 40(6):445-56. doi:10.1016/j.exphem.2012.01.015